27
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Two founder mutations in the SEC23B gene account for the relatively high frequency of CDA II in the Italian population

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Congenital Dyserythropoietic Anemia type II is an autosomal recessive disorder characterized by unique abnormalities in the differentiation of cells of the erythroid lineage. The vast majority of CDA II cases result from mutations in the SEC23B gene. To date, 53 different causative mutations have been reported in 86 unrelated cases (from the CDA II European Registry), 47 of them Italian. We have now identified SEC23B mutations in 23 additional patients, 17 Italians and 6 non-Italian Europeans. The relative allelic frequency of the mutations was then reassessed in a total of 64 Italian and 45 non-Italian unrelated patients. Two mutations, E109K and R14W, account for over one-half of the cases of CDA II in Italy. Whereas the relative frequency of E109K is similar in Italy and in the rest of Europe (and is also prevalent in Moroccan Jews), the relative frequency of R14W is significantly higher in Italy (26.3% vs. 10.7%). By haplotype analysis we demonstrated that both are founder mutations in the Italian population. By using the DMLE+ program our estimate for the age of the E109K mutation in Italian population is ≈2,200 years; whereas for the R14W mutation it is ≈3,000 years. We hypothesize that E109K may have originated in the Middle East and may have spread in the heyday of the Roman Empire. Instead, R14W may have originated in Southern Italy. The relatively high frequency of the R14W mutation may account for the known increased prevalence of CDA II in Italy. Am. J. Hematol. 86:727–732, 2011. © 2011 Wiley-Liss, Inc.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: found
          • Article: not found

          Cross-cultural estimation of the human generation interval for use in genetics-based population divergence studies.

          The length of the human generation interval is a key parameter when using genetics to date population divergence events. However, no consensus exists regarding the generation interval length, and a wide variety of interval lengths have been used in recent studies. This makes comparison between studies difficult, and questions the accuracy of divergence date estimations. Recent genealogy-based research suggests that the male generation interval is substantially longer than the female interval, and that both are greater than the values commonly used in genetics studies. This study evaluates each of these hypotheses in a broader cross-cultural context, using data from both nation states and recent hunter-gatherer societies. Both hypotheses are supported by this study; therefore, revised estimates of male, female, and overall human generation interval lengths are proposed. The nearly universal, cross-cultural nature of the evidence justifies using these proposed estimates in Y-chromosomal, mitochondrial, and autosomal DNA-based population divergence studies.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            What makes a good genetic association study?

            Genetic association studies are central to efforts to identify and characterise genomic variants underlying susceptibility to multifactorial disease. However, obtaining robust replication of initial association findings has proved difficult. Much of this inconsistency can be attributed to inadequacies in study design, implementation, and interpretation--inadequately powered sample groups are a major concern. Several additional factors affect the quality of any given association study, with appropriate sample-recruitment strategy, logical variant selection, minimum genotyping error, relevant data analysis, and valid interpretation all essential to generation of robust findings. Replication has a vital role in showing that associations that are identified reflect interesting biological processes rather than methodological quirks. For an unbiased view of the evidence for and against any particular association, study quality, rather than significance value, needs to play the dominant part.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in the SEC23B gene.

              Congenital dyserythropoietic anemia type II (CDAII) is an autosomal recessive disease characterized by ineffective erythropoiesis, hemolysis, erythroblast morphological abnormalities, and hypoglycosylation of some red blood cell (RBC) membrane proteins. Recent studies indicated that CDAII is caused by a defect disturbing Golgi processing in erythroblasts. A linkage analysis located a candidate region on chromosome 20, termed the CDAN2 locus, in the majority of CDAII patients but the aberrant gene has not so far been elucidated. We used a proteomic-genomic approach to identify SEC23B as the candidate gene for CDAII by matching the recently published data on the cytoplasmic proteome of human RBCs with the chromosomic localization of CDAN2 locus. Sequencing analysis of SEC23B gene in 13 CDAII patients from 10 families revealed 12 different mutations: six missense (c.40C>T, c.325G>A, c.1043A>C, c.1489C>T, c.1808C>T, and c.2101C>T), two frameshift (c.428_428delAinsCG and c.1821delT), one splicing (c.689+1G>A), and three nonsense (c.568C>T, c.649C>T, and c.1660C>T). Mutations c.40C>T and c.325G>A were detected in unrelated patients. SEC23B is a member of the Sec23/Sec24 family, a component of the COPII coat protein complex involved in protein transport through membrane vesicles. Abnormalities in this gene are likely to disturb endoplasmic reticulum (ER)-to-Golgi trafficking, affecting different glycosylation pathways and ultimately accounting for the cellular phenotype observed in CDAII.
                Bookmark

                Author and article information

                Journal
                Am J Hematol
                ajh
                American Journal of Hematology
                Wiley Subscription Services, Inc., A Wiley Company
                0361-8609
                1096-8652
                September 2011
                14 June 2011
                : 86
                : 9
                : 727-732
                Affiliations
                [1 ]simpleCEINGE Biotecnologie Avanzate Napoli, Italy
                [2 ]simpleDepartment of Biochemistry and Medical Biotechnologies, University of Naples Federico II Napoli, Italy
                [3 ]simpleDepartment of Biomedical Sciences and Biotechnologies, University of Study of Cagliari Cagliari, Italy
                [4 ]simpleIstituto Toscano Tumori Florence, Italy
                [5 ]simpleUMR_S 779, INSERM, Faculté de Médecine Paris-Sud, Université Paris-Sud 94275 Le Kremlin-Bicêtre, Paris, France
                [6 ]simplePediatric Hematology/Oncology Division, Schneider Children's Medical Center of Israel and Sackler Faculty of Medicine, Tel-Aviv University Tel-Aviv, Israel
                Author notes
                *Correspondence to: Achille Iolascon, MD, PhD, CEINGE, Biotecnologie Avanzate, Via Gaetano Salvatore 486, 80145 Naples, Italy. E-mail: achille.iolascon@ 123456unina.it

                Conflict of interest: Nothing to report.

                Additional Supporting Information may be found in the online version of this article.

                Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms

                Contract grant sponsor: Italian Ministero dell'Universitàe della Ricerca, by Telethon (Italy) (GGP09044); Contract grant number: MUR-PS 35-126/Ind; Contract grant sponsor: Regione Campania; Contract grant number: DGRC 1901/2009.

                Article
                10.1002/ajh.22096
                3258542
                21850656
                e5e54a59-dbb1-47ff-945c-2982072ebc77
                Copyright © 2011 Wiley-Liss, Inc., A Wiley Company

                Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.

                History
                : 23 May 2011
                : 26 May 2011
                Categories
                Research Article

                Hematology
                Hematology

                Comments

                Comment on this article